Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 38351-38400 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT06682195
Neoadjuvant Chemotherapy Combined With Toripalimab for TNBC (NEOTORCH-BREAST02)
PHASE2Recruiting
35 participants
Started: Oct 9, 2024 · Completed: Oct 1, 2029
1 condition1 sponsor13 locations
NCT05984433
Auricular Acupuncture as Part of Multimodal Analgesia After Lower Leg Fracture
NARecruiting
140 participants
Started: Oct 9, 2024 · Completed: Dec 31, 2026
4 conditions1 sponsor1 location
NCT06643416
Efficacy and Safety of Add-on Timolol for EGFR-TKI and ALK-TKI Induced Paronychia
PHASE3Recruiting
40 participants
Started: Oct 9, 2024 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT06279442
Adrenal Project: Clinical and Epidemiological Characterization of Adrenocortical Carcinoma in a Brazilian Cohort
N/ARecruiting
150 participants
Started: Oct 9, 2024 · Completed: Aug 25, 2025
2 conditions1 sponsor10 locations
NCT06506019
Neurobiological Effects of Psilocybin in Treatment Resistant Bipolar Depression
PHASE1Recruiting
30 participants
Started: Oct 9, 2024 · Completed: Jan 1, 2027
1 condition2 sponsors1 location
NCT06583031
Study to Evaluate the Safety and Immune Response of an Investigational Vaccine for the Prevention of RSV (Respiratory Syncytial Virus) and (hMPV) Human Metapneumovirus Infection in Participants Aged 60 to 75 Years
PHASE1Active, not recruiting
385 participants
Started: Oct 9, 2024 · Completed: Sep 28, 2025
2 conditions1 sponsor6 locations
NCT06630286
Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed People With HIV-1
PHASE3Active, not recruiting
609 participants
Started: Oct 9, 2024 · Completed: Aug 31, 2030
1 condition1 sponsor106 locations
NCT06590220
Establishment of Multiparametric Prediction Models for Moderate to SevereThyroid Associated Ophthalmopathy
N/ARecruiting
150 participants
Started: Oct 9, 2024 · Completed: Sep 6, 2028
1 condition1 sponsor1 location
NCT06588920
Brain Activity, Cognitive Function, and Walking Ability in Parkinson's Disease
N/ARecruiting
70 participants
Started: Oct 9, 2024 · Completed: Aug 31, 2027
2 conditions1 sponsor2 locations
NCT07057726
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SSS39 Injection in Healthy Chinese Subjects
PHASE1Enrolling by invitation
48 participants
Started: Oct 9, 2024 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT06659666
The COPD Optimiser
N/AEnrolling by invitation
100 participants
Started: Oct 9, 2024 · Completed: Feb 28, 2025
1 condition2 sponsors2 locations
NCT06650566
Study of LM-299 in Subjects Advanced Malignant Tumors
PHASE1/PHASE2Recruiting
108 participants
Started: Oct 9, 2024 · Completed: Jul 31, 2027
1 condition1 sponsor6 locations
NCT06476483
Feasibility and Acceptability of Implementing DIALOG+ in a Psychiatric Rehabilitation Unit
NAEnrolling by invitation
12 participants
Started: Oct 9, 2024 · Completed: May 30, 2025
1 condition2 sponsors1 location
NCT06444880
Phase II Trial of Ubamatamab Alone or in Combination With Cemiplimab in MUC16-Expressing SMARCB1-Deficient Malignancies
PHASE2Recruiting
40 participants
Started: Oct 9, 2024 · Completed: Jul 31, 2028
1 condition2 sponsors1 location
NCT06593691
Examining the Effectiveness of Multiwave Locked System Laser Treatment in Chronic Low Back Pain
NARecruiting
110 participants
Started: Oct 9, 2024 · Completed: Aug 31, 2026
1 condition1 sponsor1 location
NCT06419179
Maintenance Durvalumab (MEDI4736) and Olaparib (AZD2281) After Standard 1st Line Treatment (Carboplatin/Cisplatin, Etoposide, Durvalumab) in HRD Positive Extensive Disease (ED) Small-cell Lung Cancer (SCLC)
PHASE2Enrolling by invitation
29 participants
Started: Oct 9, 2024 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT06367075
A Trial of Cadonilimab With Adriamycin in Patients With Advanced Soft Tissue Sarcoma
PHASE2Recruiting
53 participants
Started: Oct 9, 2024 · Completed: Mar 31, 2029
1 condition7 sponsors1 location
NCT06630741
Support and Personalized Care in Alternative Midwifery Birth Units Versus Traditional Units in France: Effects on the Psychological Health of Couples and on the Health of the Mother and Child at the Age of 2 Years.
N/ARecruiting
748 participants
Started: Oct 9, 2024 · Completed: Jul 9, 2025
1 condition1 sponsor3 locations
NCT06877312
Longitudinal Study to Investigate Different Transcranial Electrical Stimulation
NARecruiting
200 participants
Started: Oct 9, 2024 · Completed: Dec 31, 2033
1 condition1 sponsor1 location
NCT06361173
Spanish BMT4me Usability & Acceptability
N/ARecruiting
30 participants
Started: Oct 9, 2024 · Completed: May 1, 2026
1 condition2 sponsors2 locations
NCT06786026
QL1706 Plus Chemotherapy +/- Bevacizumab in 1L Treatment of R/mTNBC
PHASE2Recruiting
60 participants
Started: Oct 9, 2024 · Completed: Dec 31, 2028
1 condition1 sponsor1 location
NCT06829940
Efficacy of Baduanjin Exercise in COVID-19 Contraction Patients With Idiopathic Chronic Fatigue
NARecruiting
40 participants
Started: Oct 9, 2024 · Completed: Mar 1, 2025
1 condition1 sponsor1 location
NCT06474728
Effects of an Emollient Containing Postbiotic Saccharomyces and Lactobacillus on Pediatric Atopic Dermatitis
NARecruiting
98 participants
Started: Oct 9, 2024 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT07098598
Pancreatic Cancer Diagnosis With FAPI-PET Imaging
PHASE2/PHASE3Recruiting
100 participants
Started: Oct 9, 2024 · Completed: Oct 31, 2026
8 conditions1 sponsor1 location
NCT06510231
Inspiratory Muscle Training in HFpEF
NARecruiting
68 participants
Started: Oct 9, 2024 · Completed: Apr 30, 2028
1 condition2 sponsors1 location
NCT06632691
Virtual Reality Headset and Acceptability of Rectosigmoidoscopy in Ulcerative Colitis: a Randomised Controlled Trial
NARecruiting
100 participants
Started: Oct 9, 2024 · Completed: Apr 9, 2027
1 condition1 sponsor2 locations
NCT05996185
Study of Mogamulizumab With DA-EPOCH in Patients With Aggressive T Cell Lymphoma
PHASE2Recruiting
22 participants
Started: Oct 9, 2024 · Completed: Nov 30, 2027
1 condition2 sponsors1 location
NCT06975332
Local, Targeted Therapy With Alpha Emitter [225Ac]Ac-DOTA-SP (TAT) in Glioma (WHO G3-G4) Progression
NARecruiting
35 participants
Started: Oct 9, 2024 · Completed: Sep 30, 2027
4 conditions1 sponsor2 locations
NCT06598891
PAS Balance Training for Parkinson Disease (PD)
NARecruiting
60 participants
Started: Oct 9, 2024 · Completed: May 31, 2026
1 condition1 sponsor1 location
NCT06595043
Effects of Different Occlusion Angles of Disposable Tracheal Blocker on Right One-lung Ventilation
NARecruiting
96 participants
Started: Oct 9, 2024 · Completed: Dec 31, 2025
1 condition1 sponsor3 locations
NCT06594211
Allogeneic Anti-BCMA/GPRC5D Bispecific CAR-NK Cells (ACT-001) in Patients With Relapsed or Refractorymultiple Myeloma
NANot yet recruiting
18 participants
Started: Oct 9, 2024 · Completed: Oct 9, 2028
1 condition2 sponsors1 location
NCT06014827
Biologically Guided Radiation Therapy (BgRT) and Stereotactic Body Radiation Therapy (SBRT) to Tyrosine Kinase Inhibitor in Oligoprogressive Oncogenic Positive Non-Small Cell Lung Carcinoma
PHASE2Recruiting
32 participants
Started: Oct 9, 2024 · Completed: Jul 11, 2026
2 conditions2 sponsors2 locations
NCT06525636
A First-in-human Study of KK8123 in Adults With X-linked Hypophosphatemia
PHASE1/PHASE2Recruiting
24 participants
Started: Oct 9, 2024 · Completed: May 10, 2028
1 condition2 sponsors8 locations
NCT06361836
Study of Single Doses of SBT777101 in Subjects With Hidradenitis Suppurativa
PHASE1Recruiting
24 participants
Started: Oct 9, 2024 · Completed: Nov 30, 2026
1 condition1 sponsor6 locations
NCT06632236
5G-EMERALD: Amivantamab in Malignant Brain Tumours
PHASE1Recruiting
12 participants
Started: Oct 9, 2024 · Completed: Mar 5, 2027
4 conditions7 sponsors2 locations
NCT06222203
Surveillance for Malignant Transformation of Neurofibromatosis Type 1 (NF1) Related Peripheral Nerve Sheath Tumors (PNST)
N/ARecruiting
225 participants
Started: Oct 9, 2024 · Completed: Dec 31, 2035
2 conditions1 sponsor1 location
NCT05962463
Pulsed Radiofrequency Therapy vs Canal Adductor Blockade in Knee Osteoarthritis
N/ARecruiting
128 participants
Started: Oct 9, 2024 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT06608212
An Observational Study to Learn More About How Safe Finerenone is and How Well it Works in People With Chronic Kidney Disease and Type 2 Diabetes in Routine Medical Care in the United States
N/AActive, not recruiting
150,000 participants
Started: Oct 9, 2024 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT06259409
Regenn® Therapy System Safety Study
PHASE1Recruiting
30 participants
Started: Oct 9, 2024 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT06669585
Cannabis Observations on Brain Waves, Retrieval, and Attention: Experiment 3
N/ARecruiting
64 participants
Started: Oct 9, 2024 · Completed: Jan 31, 2026
3 conditions2 sponsors1 location
NCT06423898
Ampicillin and Ceftriaxone for the Treatment of Enterococcus Faecalis Infective Endocarditis.
PHASE4Recruiting
284 participants
Started: Oct 9, 2024 · Completed: Dec 31, 2028
1 condition2 sponsors18 locations
NCT06901713
Smoking Cessation Program With CBT and Mindfulness Audio Support: A Randomized Controlled Trial
NARecruiting
2,000 participants
Started: Oct 9, 2024 · Completed: Nov 1, 2026
1 condition1 sponsor1 location
NCT06321484
Intraperitoneal Cytokine-Induced Memory Like (CIML) Natural Killer (NK) Cells in Recurrent Ovarian Cancer
PHASE1Recruiting
18 participants
Started: Oct 9, 2024 · Completed: Oct 31, 2031
5 conditions2 sponsors2 locations
NCT06635174
Efficacy of 50% Oral Dextrose As Pain Relief in Newborns Before Bladder Catheterization
NAEnrolling by invitation
90 participants
Started: Oct 9, 2024 · Completed: Mar 1, 2025
2 conditions1 sponsor1 location
NCT06626282
Fertility and Ovarian Reserve in Female Childhood Cancer Survivors
N/ARecruiting
340 participants
Started: Oct 9, 2024 · Completed: Dec 31, 2028
8 conditions2 sponsors3 locations
NCT06501612
Pilot RCT Evaluating Clinical Outcomes of Using Undermyfork Mobile App With Dexcom G7
NARecruiting
90 participants
Started: Oct 9, 2024 · Completed: Sep 30, 2026
1 condition1 sponsor1 location
NCT06588257
Acceptability of the HPV Vaccine and Anal HPV in Transgender Women and Men Who Have Sex With Men: A Pilot Study
PHASE4Active, not recruiting
101 participants
Started: Oct 9, 2024 · Completed: Apr 9, 2026
1 condition2 sponsors1 location
NCT06637462
A Study of Response to Standard Treatment Before Surgery in People With Rectal Cancer
NARecruiting
30 participants
Started: Oct 9, 2024 · Completed: Oct 9, 2027
2 conditions1 sponsor6 locations
NCT06470048
A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis
PHASE2Recruiting
200 participants
Started: Oct 9, 2024 · Completed: Jul 15, 2030
1 condition1 sponsor103 locations
NCT06472414
A Women-Focused Cardiovascular Rehabilitation Program on Adherence, Health Related Physical Fitness, and Quality of Life
NARecruiting
82 participants
Started: Oct 8, 2024 · Completed: Apr 30, 2027
1 condition2 sponsors1 location